Skip to main content
. 2020 Jun 22;217(8):e20192197. doi: 10.1084/jem.20192197

Figure 8.

Figure 8.

Visualizing retrograde migration. (A and B) Representative example of the medLN (blue shade) and medLN-associated lymphatics (red shade) dissected out for flow cytometric analysis 16 d after P14 transfer and i.n. PR8 infection. (C) Frequency of P14 cells expressing a CD103+ Ly6Clo phenotype isolated from medLN (left) or associated lymphatic vessels (right) 12–21 d after infection with PR8-gp33 (n = 5 or 6 mice per time point). Bars represent mean ± SEM. ***, P < 0.001 as determined by Student’s t test comparing day 12 to day 21. (D) 18 d after P14 cell transfer and i.n. PR8-gp33 infection, IF microscopy of the medLN and associated lymphatic vessels. Arrows indicates Ly6Clo P14 cell in lymphatic vessels. Scale bar represents 500 µm. (E) Ce3D and two-photon microscopy of the medLN and associated lymphatics 16 d after PR8 infection (Video 1). Scale bar represents 200 µm. (F) Mice infected with influenza virus 16 d earlier were treated with α-Thy1.1–depleting antibody and compared with untreated (No Tx) controls 4 d later. Numbers in top right image indicate regions enlarged in the panels below. Scale bars represent 200 µm. (G) As in F, Ly6Clo P14 cells could be identified at the medLN periphery and directly within medLN-associated lymphatics (marked by asterisk) in both untreated mice (top) and mice treated 4 d earlier with α-Thy1.1–depleting antibody (bottom). Arrows highlight influenza-specific cells that are Ly6Clo/neg. Scale bars represent 50 µm. Representative images are from at least three sections per tissue, per mouse, of three or more individual mice.